|
|
 |
|
Total Number of Holdings (excluding cash): 51
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$47,034.60 |
2.40% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$43,529.60 |
2.22% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$42,780.73 |
2.18% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$42,291.00 |
2.16% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$42,182.46 |
2.15% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$41,602.50 |
2.12% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$41,208.00 |
2.10% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$40,916.46 |
2.09% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$40,900.15 |
2.08% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$40,835.18 |
2.08% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$40,728.44 |
2.08% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$40,536.10 |
2.07% |
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$40,668.50 |
2.07% |
| Waters Corporation |
WAT |
941848103 |
121 |
$40,562.83 |
2.07% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$40,065.41 |
2.04% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$39,685.95 |
2.02% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$39,491.62 |
2.01% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$39,456.45 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$39,172.50 |
2.00% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$39,057.20 |
1.99% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$38,810.94 |
1.98% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$38,899.37 |
1.98% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$38,639.63 |
1.97% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$38,693.10 |
1.97% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$38,523.07 |
1.96% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$38,416.18 |
1.96% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,540.88 |
1.96% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$38,403.83 |
1.96% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$38,435.99 |
1.96% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$38,457.26 |
1.96% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$38,373.66 |
1.96% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$38,346.55 |
1.95% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$38,259.00 |
1.95% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$38,156.35 |
1.95% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$37,984.12 |
1.94% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$38,081.02 |
1.94% |
| Steris Plc |
STE |
G8473T100 |
173 |
$37,964.85 |
1.94% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$37,791.88 |
1.93% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$37,747.80 |
1.92% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$37,696.68 |
1.92% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$37,710.30 |
1.92% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$37,623.31 |
1.92% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$37,386.18 |
1.91% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$37,312.20 |
1.90% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$37,140.48 |
1.89% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$36,476.60 |
1.86% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$36,244.00 |
1.85% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$35,697.20 |
1.82% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$34,903.83 |
1.78% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$34,720.61 |
1.77% |
| US Dollar |
$USD |
|
7,240 |
$7,239.87 |
0.37% |
| Swiss Franc |
$CHF |
|
235 |
$300.49 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|